Bisoprolol may increase the hypotensive activities of Manidipine. Methyl salicylate may decrease the antihypertensive activities of Perindopril. Resveratrol may decrease the antihypertensive activities of Bisoprolol. Indomethacin may decrease the antihypertensive activities of Bisoprolol. Niflumic Acid may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Zaltoprofen. Bisoprolol may increase the hypotensive activities of Latanoprost. The risk or severity of adverse effects can be increased when Perindopril is combined with Etofenamate. The serum concentration of Bisoprolol can be decreased when it is combined with Peginterferon alfa-2b. Perindopril may increase the hypotensive activities of Dorzolamide. Rilmenidine may increase the hypotensive activities of Perindopril. Nicorandil may increase the hypotensive activities of Bisoprolol. Levonordefrin may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Secobarbital may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Fimasartan is combined with Perindopril. Perindopril may increase the hypotensive activities of Celiprolol. Huperzine A may increase the bradycardic activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Metoprolol is combined with Perindopril. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Losartan. The risk or severity of adverse effects can be increased when Forasartan is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Dipyridamole. The risk or severity of adverse effects can be increased when Perindopril is combined with Apocynin. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nesiritide. The risk or severity of adverse effects can be increased when Perindopril is combined with Salsalate. Bisoprolol may increase the orthostatic hypotensive activities of Carvedilol. Bisoprolol may increase the hypotensive activities of Nilvadipine. The metabolism of Bisoprolol can be decreased when combined with Ticlopidine. Secobarbital may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Triamterene is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with E-6201. Ardeparin may increase the hyperkalemic activities of Perindopril. The metabolism of Bisoprolol can be decreased when combined with Celecoxib. The risk or severity of adverse effects can be increased when Perindopril is combined with Pregabalin. The metabolism of Bisoprolol can be decreased when combined with Sertraline. The serum concentration of Pazopanib can be increased when it is combined with Perindopril. The serum concentration of Edoxaban can be increased when it is combined with Perindopril. The serum concentration of Bisoprolol can be decreased when it is combined with Siltuximab. The risk or severity of adverse effects can be increased when Perindopril is combined with Penbutolol. Decamethonium may increase the bradycardic activities of Bisoprolol. Metoclopramide may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Benoxaprofen. The risk or severity of adverse effects can be increased when Fosinopril is combined with Perindopril. The metabolism of Bisoprolol can be decreased when combined with Nelfinavir. Bisoprolol may decrease the bronchodilatory activities of Clenbuterol. Bisoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide. Perindopril may increase the hypotensive activities of Temocapril. Reserpine may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Vinpocetine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Eprosartan. Perindopril may increase the hypotensive activities of Ambrisentan. The risk or severity of adverse effects can be increased when Doxazosin is combined with Perindopril. The risk or severity of adverse effects can be increased when Atenolol is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Tolcapone is combined with Bisoprolol. The metabolism of Bisoprolol can be increased when combined with Pentobarbital. Perindopril may increase the hypotensive activities of Platelet Activating Factor. The metabolism of Bisoprolol can be decreased when combined with Ketoconazole. The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Perindopril. Octamoxin may increase the hypotensive activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Dabrafenib. The risk or severity of adverse effects can be increased when Perindopril is combined with Nadolol. The metabolism of Bisoprolol can be decreased when combined with Cinacalcet. Bisoprolol may decrease the bronchodilatory activities of Phenylpropanolamine. Piroxicam may decrease the antihypertensive activities of Bisoprolol. Perindopril may increase the hypotensive activities of Phenoxybenzamine. The risk or severity of adverse effects can be increased when Perindopril is combined with Semapimod. Bisoprolol may increase the hypotensive activities of Efonidipine. Bisoprolol may increase the hypoglycemic activities of Gliquidone. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Dinitrate. The serum concentration of Ergonovine can be increased when it is combined with Perindopril. The serum concentration of Cyclosporine can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Floctafenine. Methohexital may increase the hypotensive activities of Perindopril. Clonixin may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Candesartan. Bisoprolol may increase the bradycardic activities of Beractant. Apocynin may decrease the antihypertensive activities of Bisoprolol. Aprotinin may decrease the antihypertensive activities of Perindopril. The metabolism of Bisoprolol can be decreased when combined with Tranylcypromine. Nimesulide may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Metolazone is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Atazanavir. Bisoprolol may increase the bradycardic activities of Rivastigmine. Trimethaphan may increase the hypotensive activities of Perindopril. The serum concentration of Bisoprolol can be decreased when it is combined with Deferasirox. The metabolism of Bisoprolol can be decreased when combined with Clobazam. The metabolism of Bisoprolol can be decreased when combined with Lumefantrine. Cryptenamine may increase the hypotensive activities of Perindopril. Mesalazine may decrease the antihypertensive activities of Perindopril. Tubocurarine may increase the bradycardic activities of Bisoprolol. The serum concentration of Sildenafil can be increased when it is combined with Perindopril. Bisoprolol may increase the hypoglycemic activities of Insulin Human. The metabolism of Bisoprolol can be decreased when combined with Ranolazine. Perindopril may increase the hypotensive activities of Theodrenaline. The metabolism of Bisoprolol can be decreased when combined with Chlorpromazine. The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Perindopril. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Perindopril. The risk or severity of adverse effects can be increased when Tretinoin is combined with Bisoprolol. Bisoprolol may increase the hypotensive activities of Nitrendipine. Bisoprolol may increase the hypotensive activities of Ticrynafen. The risk or severity of adverse effects can be increased when Nimodipine is combined with Bisoprolol. Parthenolide may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Mycophenolic acid. Bisoprolol may decrease the bronchodilatory activities of Fenoterol. The risk or severity of adverse effects can be increased when Diltiazem is combined with Bisoprolol. Brimonidine may increase the antihypertensive activities of Bisoprolol. Nepafenac may decrease the antihypertensive activities of Bisoprolol. Zomepirac may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Fenoprofen. The serum concentration of Doxorubicin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Sulindac. Bisoprolol may increase the hypotensive activities of Tolazoline. The risk or severity of adverse effects can be increased when Propofol is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Amyl Nitrite. Bosentan may increase the hypotensive activities of Perindopril. The serum concentration of Tianeptine can be increased when it is combined with Perindopril. The metabolism of Bisoprolol can be decreased when combined with Primaquine. Trans-2-Phenylcyclopropylamine may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Indoprofen. The serum concentration of Riociguat can be increased when it is combined with Perindopril. The serum concentration of Bisoprolol can be increased when it is combined with Osimertinib. Urapidil may increase the hypotensive activities of Perindopril. Perindopril may increase the hypotensive activities of BQ-123. The serum concentration of Bisoprolol can be increased when it is combined with Alaproclate. Bisoprolol may increase the hypotensive activities of Obinutuzumab. Methylphenobarbital may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Niflumic Acid. The serum concentration of Protriptyline can be increased when it is combined with Perindopril. Bethanidine may increase the hypotensive activities of Perindopril. Acepromazine may increase the hypotensive activities of Bisoprolol.